Target Audience
This activity has been designed to meet the educational needs of healthcare professionals interested in developing a greater understanding in the area of hepatitis C screening, diagnosis, and management.

Educational Objectives

  1. Review data on the global prevalence of HCV
  2. Describe the natural history of HCV
  3. Identify the detrimental effects of untreated, chronic HCV to emphasize the need for diagnosis and treatment
  4. Define "cure" in HCV and discuss treatment advances in this disease
  5. Examine the WHO Guidelines for the screening, care and treatment of persons with HCV
  6. Discuss the global implications of the WHO guidelines

Accreditation Statements & Credit Designation
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and International Coalition of Hepatology Education Providers (IC-HEP). The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.

The Annenberg Center for Health Sciences at Eisenhower designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit ™. Physicians should claim only the credits commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest

All faculty and staff involved in the planning or presentation of continuing education activities provided by Annenberg Center for Health Sciences at Eisenhower (ACHS) are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity. John Bayliss, VP, Business Development, Annenberg Center, spouse is an employee of Amgen, Inc; all other staff at the Annenberg Center for Health Sciences at Eisenhower and the International Coalition of Hepatology Education Providers have no relationships to disclose.

Learner Assurance Statement

The Annenberg Center for Health Sciences at Eisenhower is committed to resolving all conflicts of interest issues that could arise as a result of prospective faculty members' significant relationships with drug or device manufacturer(s). The Annenberg Center for Health Sciences at Eisenhower is committed to retaining only those speakers with financial interests that can be reconciled with the goals and educational integrity of the CME activity.

Faculty Disclosure Statement

The following speakers and/or planning committee members have indicated that they have relationship(s) with industry to disclose:

Raj Reddy, MD
University of Pennsylvania

Raj Reddy, MD has an advisory board membership with Bristol-Myers Squibb, Gilead, AbbVie, Merck, and Janssen. Additionally, he has received grants for clinical research from Bristol-Myers Squibb, Gilead, Janssen, AbbVie, and Merck.

Rachel Bejarano, PharmD
Rachel Bejarano has no relationships to disclose.

Release Date: December 18, 2015
Expiration Date: December 18, 2016

 

This enduring activity is supported by educational grants from AbbVie, Bristol-Myers Squibb, Gilead Sciences, Inc., and Merck.

Webcast:

(Click on the links below to view the webcast or download the slides)


Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and the International Coalition of Hepatology Education Providers.